Abstract
Human platelets are released from the cytoplasm of megakaryocytes and average 2-3 μm in diameter. In response to vascular injury, platelets stick together like glue, seal the wounded area, and dispense their contents into the nearby milieu. Taken at face value, these features and functions seem simplistic and unrefined. As one digs deeper, however, it becomes apparent that platelets are intricately wired and created for multifunctional purposes. One of their duties, which cropped up over the last decade, is to synthesize proteins both continually and on demand. It turns out that platelets possess thousands of template mRNAs, ribosomes, and requisite translational machinery that they use to generate new proteins. Platelets also retain tools that grant them the ability to process precursor mRNAs and microRNAs. In this review, we briefly describe what we currently know about protein synthesis in platelets, its functional significance, and where the field is likely to take us over the next decade.
Keywords: mRNA, platelets, protein synthesis, ribosomes, splicing, translation, synthetic pathways, megakaryocytes, thrombopoiesis, mechanisms, Leukocytes, glycoprotein
Current Proteomics
Title: Platelet Protein Synthesis and Translational Control
Volume: 8 Issue: 3
Author(s): Robert A. Campbell, Neal D. Tolley, Hansjorg Schwertz and Andrew S. Weyrich
Affiliation:
Keywords: mRNA, platelets, protein synthesis, ribosomes, splicing, translation, synthetic pathways, megakaryocytes, thrombopoiesis, mechanisms, Leukocytes, glycoprotein
Abstract: Human platelets are released from the cytoplasm of megakaryocytes and average 2-3 μm in diameter. In response to vascular injury, platelets stick together like glue, seal the wounded area, and dispense their contents into the nearby milieu. Taken at face value, these features and functions seem simplistic and unrefined. As one digs deeper, however, it becomes apparent that platelets are intricately wired and created for multifunctional purposes. One of their duties, which cropped up over the last decade, is to synthesize proteins both continually and on demand. It turns out that platelets possess thousands of template mRNAs, ribosomes, and requisite translational machinery that they use to generate new proteins. Platelets also retain tools that grant them the ability to process precursor mRNAs and microRNAs. In this review, we briefly describe what we currently know about protein synthesis in platelets, its functional significance, and where the field is likely to take us over the next decade.
Export Options
About this article
Cite this article as:
A. Campbell Robert, D. Tolley Neal, Schwertz Hansjorg and S. Weyrich Andrew, Platelet Protein Synthesis and Translational Control, Current Proteomics 2011; 8 (3) . https://dx.doi.org/10.2174/157016411797247521
DOI https://dx.doi.org/10.2174/157016411797247521 |
Print ISSN 1570-1646 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6247 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Sumoylation Pathway as Potential Therapeutic Targets in Cancer
Current Molecular Medicine Small Non-Coding RNAs as Biomarkers
Recent Patents on Biomarkers Proteasome Regulators: Activators and Inhibitors
Current Medicinal Chemistry The Role of the Complex USP1/WDR48 in Differentiation and Proliferation Processes in Cancer Stem Cells
Current Stem Cell Research & Therapy Synthesis of resveratrol acrylamides derivatives and biological evaluation of their anti-proliferative effect on cancer cell lines
Letters in Drug Design & Discovery IO Nation: The Rise of Immuno-Oncology
Current Pharmacogenomics and Personalized Medicine Novel Genetic and Peptide-Based Strategies Targeting the Bcl-2 Family, an Update
Recent Patents on DNA & Gene Sequences Nano-Based Therapy for Treatment of Skin Cancer
Recent Patents on Anti-Infective Drug Discovery DNA-Damaging Anticancer Drugs – A Perspective for DNA Repair- Oriented Therapy
Current Medicinal Chemistry The Potential of 11C-acetate PET for Monitoring the Fatty Acid Synthesis Pathway in Tumors
Current Pharmaceutical Biotechnology An Overview of the Chemistry and Pharmacological Potentials of Furanones Skeletons
Current Organic Chemistry Pharmacogenomic Approaches for Tailored Anti-Leukemic Therapy in Children
Current Medicinal Chemistry MIIP, a Cytoskeleton Regulator that Blocks Cell Migration and Invasion, Delays Mitosis, and Suppresses Tumorogenesis
Current Protein & Peptide Science Transcription Factor NF-κB Inhibitors as Single Therapeutic Agents or in Combination with Classical Chemotherapeutic Agents for the Treatment of Hematologic Malignancies
Current Molecular Pharmacology Ribonucleotide Reductase: A Mechanistic Portrait of Substrate Analogues Inhibitors
Current Medicinal Chemistry Selective Histone Deacetylase Inhibitors
Anti-Cancer Agents in Medicinal Chemistry Anti-inflammatory Phytochemicals for Chemoprevention of Colon Cancer
Current Cancer Drug Targets The Potential Therapeutic Use of Stem Cells in Cartilage Repair
Current Stem Cell Research & Therapy Data Visualization and Feature Selection Methods in Gel-based Proteomics
Current Protein & Peptide Science Gammadelta T Lymphocytes Producing IFNγ and IL-17 in Response to Candida Albicans or Mycobacterial Antigens: Possible Implications for Acute and Chronic Inflammation
Current Medicinal Chemistry